Canopus BioPharma Incorporated
CBIA · OTC
8/31/2022 | 8/31/2021 | 6/30/2014 | 6/30/2013 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$765 | -$2 | -$851 | -$526 |
| Dep. & Amort. | $0 | $0 | -$10 | -$10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $8 | $0 | -$74 | -$12 |
| Other Non-Cash | $750 | $0 | $2,863 | $4 |
| Operating Cash Flow | -$6 | -$2 | $1,928 | -$544 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $0 | -$2,308 | $464 |
| Investing Cash Flow | $0 | $0 | -$2,308 | $464 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $33 | $31 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $378 | $80 |
| Financing Cash Flow | $10 | $0 | $409 | $80 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$30 | $29 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | -$2 | $29 | $0 | $0 |
| End Cash | $4 | -$2 | $29 | -$0 |
| Free Cash Flow | -$6 | -$2 | $1,928 | -$544 |